An enzyme-sensitive, biodegradable amphiphilic polymeric conjugate, pHPMA-Gd-PTX-Cy5.5 (about 92 kDa, self-assembled into roughly 85 nm nanoparticles), was reported in 2018 as a theranostic nanomedicine combining magnetic resonance imaging, fluorescence tracking, and paclitaxel chemotherapy. Its per-gadolinium longitudinal relaxivity (r1=12.9r_1 = 12.9 mM−1^{-1}s−1^{-1} at 1.5 T) is about five times that of the clinical agent Gd-DTPA, but the origin of this enhancement was attributed only qualitatively to a longer rotational correlation time, and organ gadolinium burdens were followed only to 96 h after injection. The open problem is the twin validation of this platform: quantitatively dissect the relaxivity enhancement among rotational slowing, inner-sphere water exchange, and second-sphere contributions, and establish the long-term fate and chronic safety of residual gadolinium and polymer fragments beyond the 96 h observation window. Neither question has been addressed in the literature.

Background

Magnetic resonance imaging (MRI) contrast agents for T1-weighted imaging are most commonly small-molecule chelates of gadolinium, Gd(III), such as Gd-DTPA (gadolinium diethylenetriaminepentaacetic acid) or the macrocyclic chelate Gd-DOTA (DOTA is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid). Their efficacy is quantified by the longitudinal relaxivity r1r_1, the slope of the water-proton relaxation rate 1/T11/T_1 versus gadolinium concentration (units mM−1^{-1}s−1^{-1} per Gd center). According to the Solomon-Bloembergen-Morgan theory of paramagnetic relaxation, r1r_1 is governed mainly by (i) the rotational correlation time τR\tau_R, the characteristic tumbling time of the Gd complex, (ii) the residence time τM\tau_M of the water molecule coordinated in the inner sphere of Gd(III) (its exchange rate with bulk water), and (iii) contributions from second-sphere water molecules held near the chelate by hydrogen bonds. Conjugating many Gd chelates to a macromolecule slows tumbling (larger τR\tau_R) and therefore raises r1r_1; this is the standard rationale for polymeric contrast agents. The established experimental toolkit for quantitatively attributing relaxivity among these mechanisms combines nuclear magnetic relaxation dispersion (NMRD, the field dependence of r1r_1), 17{}^{17}O NMR measurements of the water-exchange rate, and electron paramagnetic resonance (EPR), analyzed jointly with a Lipari-Szabo-type analysis (a model-free treatment separating fast internal motion of the chelate from slow overall tumbling of the macromolecule); it has been applied to dendrimer, inulin, and other macromolecular Gd conjugates, but not to the polymer family at issue here. A parallel safety concern drives this field: retained gadolinium from Gd-based agents is linked to nephrogenic systemic fibrosis and to gadolinium deposition in brain and other tissues, so any agent whose gadolinium circulates for days in nanoparticles must demonstrably clear.

Polymer theranostics aim to combine imaging and therapy on one macromolecular carrier. The archetypal carrier is the water-soluble, biocompatible copolymer of N-(2-hydroxypropyl)methacrylamide (HPMA), synthesized by RAFT (reversible addition-fragmentation chain transfer, a controlled radical polymerization giving predictable molecular weights). A key design element is the tetrapeptide GFLG (Gly-Phe-Leu-Gly), which is cleaved by cathepsin B, a lysosomal protease overexpressed in tumors: embedding GFLG in the polymer backbone lets a high-molecular-weight carrier (above the roughly 50 kDa renal-filtration threshold) fragment into renally excretable pieces after cellular uptake. Nanoparticles of tens to hundreds of nanometers also passively accumulate in tumors through the EPR (enhanced permeability and retention) effect.

In this context, Cai and co-workers (Applied Materials Today 11 (2018) 207-218) synthesized by two-step RAFT polymerization an amphiphilic triblock HPMA copolymer bearing paclitaxel (PTX) attached through the GFLG linker, DOTA chelators loaded with Gd(III), and the near-infrared fluorophore Cyanine5.5 (pHPMA-Gd-PTX-Cy5.5; about 92 kDa, degrading to about 44 kDa fragments under cathepsin B; nanoparticles of roughly 85 nm). The conjugate showed r1=12.9r_1 = 12.9 mM−1^{-1}s−1^{-1} at 1.5 T versus 2.4 mM−1^{-1}s−1^{-1} for Gd-DTPA measured identically (a 5.4-fold enhancement), strong antitumor activity in mice bearing 4T1 tumors (4T1 is a mouse mammary carcinoma cell line; 95.5% tumor growth inhibition), tumor accumulation of about 6.9% of the injected dose per gram at 24 h, falling hepatic and splenic Gd burdens between 24 h and 96 h (liver about 26% to 14% ID/g; spleen about 11% to 4% ID/g by inductively coupled plasma mass spectrometry, ICP-MS), and no histopathological abnormalities at the tested dose and times. What the study could not establish is exactly what the title questions ask: the relaxivity enhancement was attributed only qualitatively to a size-induced prolongation of τR\tau_R, with no measurement of τR\tau_R, water exchange, or second-sphere contributions; the fate of the polymer fragments and residual Gd(III) was not followed beyond 96 h; and the toxicology was limited to short-term histology at a single dosing regimen.

Problem Statement

For the enzyme-sensitive biodegradable pHPMA-Gd-PTX-Cy5.5 theranostic platform of Cai et al. (2018), two scientifically linked questions remain open; they share one objective, a mechanistically explained and chronically safe biodegradable polymeric Gd MRI theranostic.

(1) Mechanism of the relaxivity enhancement. Establish quantitatively why the conjugate's longitudinal relaxivity (r1≈12.9r_1 \approx 12.9 mM−1^{-1}s−1^{-1} per Gd at 1.5 T, about five times Gd-DTPA under identical conditions) is so high, attributing the observed enhancement among rotational slowing (the rotational correlation time τR\tau_R of the Gd(III)-DOTA moieties on the self-assembled nanoparticle), inner-sphere water exchange (the residence time τM\tau_M of the coordinated water molecule), and second-sphere contributions. The source study attributed the enhancement only qualitatively to a size-induced prolongation of τR\tau_R, without measuring τR\tau_R, water exchange, or second-sphere contributions.

(2) Long-term fate and chronic safety. Determine what happens to the platform beyond the 96 h observation window: the biodistribution and terminal clearance of Gd(III) and of the polymer degradation fragments (weeks-to-months time course, quantitative organ burdens including liver, spleen, kidney, and brain), whether residual Gd(III) persists in tissue (with its potential for chronic retention and delayed toxicity given the reticuloendothelial accumulation, that is uptake by the liver and spleen macrophages of the mononuclear phagocyte system, observed at 24 h), and the chronic toxicity profile beyond the short-term histology at a single dose reported in the source study.

References

  1. Hao Cai, Xiaojie Wang, Hu Zhang, Ling Sun, Dayi Pan, Qiyong Gong, Zhongwei Gu, Kui Luo (2018). Enzyme-sensitive biodegradable and multifunctional polymeric conjugate as theranostic nanomedicine. Applied Materials Today 11:207-218. DOI: 10.1016/j.apmt.2018.02.003. URL: https://doi.org/10.1016/j.apmt.2018.02.003
  2. Xue Li, Ling Sun, Xiaoli Wei, Qiang Luo, Hao Cai, Xueyang Xiao, Hongyan Zhu, Kui Luo (2017). Stimuli-responsive biodegradable and gadolinium-based poly[N-(2-hydroxypropyl) methacrylamide] copolymers: their potential as targeting and safe magnetic resonance imaging probes. Journal of Materials Chemistry B 5:2763-2774. DOI: 10.1039/c6tb03253b. URL: https://doi.org/10.1039/c6tb03253b
  3. Qiang Luo, Xueyang Xiao, Xinghang Dai, Zhenyu Duan, Dayi Pan, Hongyan Zhu, Xue Li, Ling Sun, Kui Luo, Qiyong Gong (2018). Cross-Linked and Biodegradable Polymeric System as a Safe Magnetic Resonance Imaging Contrast Agent. ACS Applied Materials & Interfaces 10:1575-1588. DOI: 10.1021/acsami.7b16345. URL: https://doi.org/10.1021/acsami.7b16345
  4. Shiwei Guo, Xueyang Xiao, Xiaoming Wang, Qiang Luo, Hongyan Zhu, Hu Zhang, Haonan Li, Qiyong Gong, Kui Luo (2019). Reductive microenvironment responsive gadolinium-based polymers as potential safe MRI contrast agents. Biomaterials Science 7:1919-1932. DOI: 10.1039/c8bm01103f. URL: https://doi.org/10.1039/c8bm01103f
  5. Xiaoming Wang, Shiwei Guo, Zhiqian Li, Xueyang Xiao, Lei Gu, Qiang Luo, Hu Zhang, Qiyong Gong, Kui Luo (2019). Safe and potent MRI contrast agents by complexing gadolinium with enzyme/reduction dual-sensitive branched polymers. Applied Materials Today 17:92-103. DOI: 10.1016/j.apmt.2019.07.019. URL: https://doi.org/10.1016/j.apmt.2019.07.019
  6. Hao Cai, Xinghang Dai, Xiaoming Wang, Ping Tan, Lei Gu, Qiang Luo, Xiuli Zheng, Zhiqian Li, Hongyan Zhu, Hu Zhang, Zhongwei Gu, Qiyong Gong, Kui Luo (2020). A Nanostrategy for Efficient Imaging-Guided Antitumor Therapy through a Stimuli-Responsive Branched Polymeric Prodrug. Advanced Science 7:1903243. DOI: 10.1002/advs.201903243. URL: https://doi.org/10.1002/advs.201903243
  7. Hao Cai, Yufan Xiang, Yujun Zeng, Zhiqian Li, Xiuli Zheng, Qiang Luo, Hongyan Zhu, Qiyong Gong, Zhongwei Gu, Yanhui Liu, Hu Zhang, Kui Luo (2021). Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment. Acta Pharmaceutica Sinica B 11:544-559. DOI: 10.1016/j.apsb.2020.07.023. URL: https://doi.org/10.1016/j.apsb.2020.07.023
  8. Bing Wang, Haonan Li, Zhiqian Li, Qiang Luo, Zhongwei Gu, Hu Zhang, Qiyong Gong, Kui Luo (2021). Amphiphilic block polymer-gadolinium conjugates: Design, synthesis and application as efficient and safe nanoscale magnetic resonance imaging contrast agents. Chemical Engineering Journal 416:129170. DOI: 10.1016/j.cej.2021.129170. URL: https://doi.org/10.1016/j.cej.2021.129170
  9. Haonan Li, Yujun Zeng, Hu Zhang, Zhongwei Gu, Qiyong Gong, Kui Luo (2021). Functional gadolinium-based nanoscale systems for cancer theranostics. Journal of Controlled Release 329:482-512. DOI: 10.1016/j.jconrel.2020.08.064. URL: https://doi.org/10.1016/j.jconrel.2020.08.064
  10. Beatriz Brito, Thomas W. Price, Juan Gallo, Manuel Bañobre-López, Graeme J. Stasiuk (2021). Smart magnetic resonance imaging-based theranostics for cancer. Theranostics 11:8706-8737. DOI: 10.7150/thno.57004. URL: https://doi.org/10.7150/thno.57004
  11. Yujun Zeng, Haonan Li, Zhiqian Li, Qiang Luo, Hongyan Zhu, Zhongwei Gu, Hu Zhang, Qiyong Gong, Kui Luo (2020). Engineered gadolinium-based nanomaterials as cancer imaging agents. Applied Materials Today 20:100686. DOI: 10.1016/j.apmt.2020.100686. URL: https://doi.org/10.1016/j.apmt.2020.100686
  12. Frank A. Dunand, Éva Tóth, Robert Hollister, André E. Merbach (2001). Lipari-Szabo approach as a tool for the analysis of macromolecular gadolinium(III)-based MRI contrast agents illustrated by the [Gd(EGTA-BA-(CH2)12)]nn+_n^{n+} polymer. Journal of Biological Inorganic Chemistry 6(3):247-255. DOI: 10.1007/s007750000193. URL: https://doi.org/10.1007/s007750000193
  13. Luigi Granato, Luce Vander Elst, Celine Henoumont, Robert N. Muller, Sophie Laurent (2018). Optimizing Water Exchange Rates and Rotational Mobility for High-Relaxivity of a Novel Gd-DO3A Derivative Complex Conjugated to Inulin as Macromolecular Contrast Agents for MRI. Chemistry & Biodiversity 15(2):e1700487. DOI: 10.1002/cbdv.201700487. URL: https://doi.org/10.1002/cbdv.201700487
  14. Luigi Granato, Dario Longo, Sebastien Boutry, Luce Vander Elst, Celine Henoumont, Silvio Aime, Robert N. Muller, Sophie Laurent (2019). Synthesis and Relaxometric Characterization of New Poly[N,N-bis(3-aminopropyl)glycine] (PAPGly) Dendrons Gd-Based Contrast Agents and Their in Vivo Study by Using the Dynamic Contrast-Enhanced MRI Technique at Low Field (1 T). Chemistry & Biodiversity 16(11):e1900322. DOI: 10.1002/cbdv.201900322. URL: https://doi.org/10.1002/cbdv.201900322
  15. Shengxiang Fu, Zhongyuan Cai, Li Liu, Xiaomin Fu, Chunchao Xia, Su Lui, Qiyong Gong, Bin Song, Hua Ai (2023). PEGylated Amphiphilic Gd-DOTA Backboned-Bound Branched Polymers as Magnetic Resonance Imaging Contrast Agents. Biomacromolecules 24:5998-6008. DOI: 10.1021/acs.biomac.3c00987. URL: https://doi.org/10.1021/acs.biomac.3c00987